Skip to main content
. 2020 Oct 19;11:5271. doi: 10.1038/s41467-020-19058-4

Fig. 5. High-throughput drug testing of multiple patients on chip.

Fig. 5

a Heatmaps of organoids from three patients grown and stimulated in a simultaneous experiment. Cellular apoptosis (caspase 3/7) and death (propidium iodide) were recorded over the 72-h drug treatment period to assess drug sensitivity. b End-point analysis of average organoid cellular apoptosis and death for each patient and combination treatment group. All data presented as mean values ± SEM, n = 3, and normalized to positive control. Response comparisons between the different patients revealed distinct sensitivities to specific drug regimens across both independent cell viability assays. Source data for panels a, b are available.